Clinical Trial Update: Effect of V0251 in Acute Vertigo [Phase 2]

View source ↗

Summary

This is a Phase 2 trial update reporting the completion of a study evaluating V0251 for acute vertigo.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vertigo

Drugs mentioned

• V0251

Snippet

Sponsor: Pierre Fabre Medicament | Conditions: Acute Vertigo | Phase 2 | Status: COMPLETED